A nephrologist ran down the initial steps hospitalists should take after admitting a long-term dialysis patient during a lecture at Internal Medicine Meeting 2022.
11 May 2022
Patients taking an angiotensin receptor-neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter-2 inhibitor showed the greatest reduction in risk of death, the analysis of heart failure with reduced ejection fraction found.
15 Dec 2021
Twenty interpreters at a U.S. academic medical center reported in interviews that heart failure etiology, prognosis, and treatment options were difficult to explain clearly to patients with limited English proficiency.
11 May 2022
Discharge of heart failure patients to settings not recommended by therapists linked to increased readmission risk
Patients hospitalized with congestive heart failure who were discharged to a less intensive postacute setting than that recommended by physical and occupational therapists were more likely to be readmitted within 30 days than those discharged according to recommendations.
4 Aug 2021
Hospitalists should think beyond the Revised Cardiac Risk Index when providing preoperative assessments, attendees at Internal Medicine Meeting 2022 learned.
4 May 2022
An intervention targeting hospital clinicians had no significant effect on time to first heart failure rehospitalization or death or quality-of-care scores among patients discharged after hospitalization for acute heart failure with reduced ejection fraction, a recent trial found.
4 Aug 2021
Heart failure hospitalizations among adults ages 18 to 45 years increased from 2013 to 2018. More than half of patients were Black, and 45.8% lived in ZIP codes in the lowest quartile of national household income, a study found.
27 Apr 2022
Many heart failure patients were still prescribed albuterol, metformin, or diltiazem at discharge, as well as many other medications on the American Heart Association's list of drugs that can precipitate or induce heart failure.
13 Nov 2019
In addition to approving a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for use in heart failure with preserved ejection fraction, the FDA recently warned about certain ventilators failing and a possible risk of cancer with a lymphoma medication.
16 Mar 2022
Beta-blockers after discharge associated with improved outcomes in older patients with heart failure
Ninety-day mortality and readmission rates were significantly lower in Medicare patients who received a beta-blocker after hospital discharge for heart failure with reduced ejection fraction than in those who did not, even if they were 75 years of age and older.
16 Jun 2021